Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells
Open Access
- 15 March 2021
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 8 (10), 2004344
- https://doi.org/10.1002/advs.202004344
Abstract
Colorectal cancer, one of the most commonly diagnosed cancers worldwide, is often accompanied by uncontrolled proliferation of tumor cells. Dyskerin pseudouridine synthase 1 (DKC1), screened using the genome‐wide RNAi strategy, is a previously unidentified key regulator that promotes colorectal cancer cell proliferation. Enforced expression of DKC1, but not its catalytically inactive mutant D125A, accelerates cell growth in vitro and in vivo. DKC1 knockdown or its inhibitor pyrazofurin attenuates cell proliferation. Proteomics, RNA immunoprecipitation (RIP)‐seq, and RNA decay analyses reveal that DKC1 binds to and stabilizes the mRNA of several ribosomal proteins (RPs), including RPL10A, RPL22L1, RPL34, and RPS3. DKC1 depletion significantly accelerates mRNA decay of these RPs, which mediates the oncogenic function of DKC1. Interestingly, these DKC1‐regulated RPs also interact with HRAS and suppress the RAS/RAF/MEK/ERK pathway. Pyrazofurin and trametinib combination synergistically restrains colorectal cancer cell growth in vitro and in vivo. Furthermore, DKC1 is markedly upregulated in colorectal cancer tissues compared to adjacent normal tissues. Colorectal cancer patients with higher DKC1 expression has consistently poorer overall survival and progression‐free survival outcomes. Taken together, these data suggest that DKC1 is an essential gene and candidate therapeutic target for colorectal cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81672744, 81902845)
- Fundamental Research Funds for the Central Universities (20ykzd23)
This publication has 44 references indexed in Scilit:
- H/ACA Small RNA Dysfunctions in Disease Reveal Key Roles for Noncoding RNA Modifications in Hematopoietic Stem Cell DifferentiationCell Reports, 2013
- RNA pseudouridylation: new insights into an old modificationTrends in Biochemical Sciences, 2013
- Dyskeratosis congenita as a disorder of telomere maintenanceMutation research. Reviews in mutation research, 2012
- The genetics of dyskeratosis congenitaCancer Genetics, 2011
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's EpitheliumGastroenterology, 2011
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- Ribosomal Protein S3: A KH Domain Subunit in NF-κB Complexes that Mediates Selective Gene RegulationCell, 2007
- Reduction of invasion in human fibrosarcoma cells by ribosomal protein S3 in conjunction with Nm23-H1 and ERKBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy controlBritish Journal of Cancer, 2006
- Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseasesJournal of Chromatography B, 2004